Skip to main content

Table 2 Characteristics of patients included in the western blot study

From: Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain

Variables Controls (n = 6) AD (n = 10) P-value
Age at death (years)
 Median [IQR] 74.0 [70.5–80.0] 81.0 [78.0–85.0] 0.032
 Range 67.0–86.0 62.0–89.0  
 Female gender, n (%) 2 (33.3) 5 (55.5) NS
Post mosterm interval
 Median [IQR] 17.5 [12.0–22.0] 8 [7.5–23.0] NS
 Range 4.0–36.0 6.0–50.0  
 Missing (n) 1 0  
“A” Thal - n of patients (%)    < 0.001
 3 (4 and 5) 0 (0) 8 (80)  
 2 (3) 0 (0) 1 (10)  
 1 (1 and 2) 1 (16.7) 1 (10)  
 0 (None) 5 (83.3) 0 (0)  
“B” Braak Stage - n of patients (%)    < 0.001
 3 (V and VI) 0 (0) 10 (100)  
 2 (III and IV) 0 (0) 0 (0)  
 1 (I and II) 5 (83.3) 0 (0)  
 0 (None) 1 (16.7) 0 (0)